Cyclerion Therapeutics, Inc.
Develops personalized biofeedback therapies for treatment-resistant depression.
CYCN | US
Overview
Corporate Details
- ISIN(s):
- US23255M1053
- LEI:
- Country:
- United States of America
- Address:
- 301 BINNEY STREET, 2142 CAMBRIDGE
- Website:
- https://www.cyclerion.com/
- Sector:
- Manufacturing
Description
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to advancing personalized therapeutic approaches for neuropsychiatric disorders. The company's primary focus is on developing a treatment for people with Treatment-Resistant Depression (TRD). Its lead program utilizes a method that combines generic anesthetics with a personalized, biofeedback-driven device. This approach is designed to reset dysregulated brainwave patterns by tailoring the therapy to each patient's specific biological needs, offering a new option for individuals who have not responded to traditional treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyclerion Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cyclerion Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyclerion Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
